The Exposomics Research Accelerator fosters interdisciplinary collaboration across Rollins and Emory to develop novel exposome-focused research programs, pilot studies, and large-scale grant applications. 

Key activities:

• Methodological innovation in exposure assessment
• Exposomics profiling
• Omics integration
• Shared analytical and laboratory resources
• Team science development
• Mentoring of trainees and early-career investigators. 

The Exposomics Research Accelerator also serves as a critical hub for connecting exposomics research with policy-relevant questions and community-engaged public health priorities.

This accelerator builds on a strong foundation of ongoing, externally funded exposomics and multi-omics research at Rollins, including NIH-supported studies of the exposome, air pollution, chemical mixtures, cancer, maternal and child health, neurodegenerative disease, ADRD, and cardiometabolic outcomes. Accelerator-supported collaborations have contributed to high-impact publications, cross-school partnerships, and the development of competitive large-scale grant proposals that position Rollins as an international leader in exposome science.